The short version
5 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 14% over the past year, to $1.04 per unit. 9 Class II recalls hit this product in the past year (Cipla USA, Inc.). Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.